At this time, Kobayashi Pharmaceutical’s Tokyo headquarters is preparing to hold an emergency shareholders meeting.

During this time, the chairman of Kobayashi Pharmaceutical Co., Ltd., that is, Jiro Kobayashi, disappeared suddenly after he left for China, and the entire Kobayashi Pharmaceutical Group was headless.

In the beginning, the shareholders of Kobayashi Pharmaceuticals were still trying every means to find the whereabouts of Jiro Kobayashi.

But they did a lot of hard work and tried, and they did not find Jiro Kobayashi.

After that, they immediately contacted Ito Takehiko, the leader of the Ito family.

I contacted Ito Yuhiko because the shareholders of Kobayashi Pharmaceuticals know that Ito Yuhiko is very optimistic about Kobayashi Pharmaceuticals and Jiro Kobayashi, and hopes to recruit Jiro Kobayashi as his son-in-law, and then buy shares in Kobayashi Pharmaceuticals.

China, in the final analysis, was

result, Nanako Ito returned, but her follower Jiro Kobayashi evaporated from the

also very concerned about this matter. After all, he is very optimistic about Jiro Kobayashi and Kobayashi Pharmaceutical too.

is currently insufficient in production capacity and has not been exported to overseas markets. Therefore, local Japanese consumers know nothing about this magic medicine. They still regard Kobayashi Niranex as

in Ito’s view, Kobayashi Pharmaceutical’s future prospects

the opportunity to invest in Kobayashi Pharmaceutical, Ito Yuhiko also sent many people to

is a pity that they don’t have a strong intelligence network in China, and they can’t get any information about

Jiro Kobayashi seemed to have completely disappeared in the eyes of the Kobayashi family

lead in giving up the search for

Kobayashi, it would be better to quickly let the Kobayashi family choose a new president, and then go to work with

Ito Takehiko, the Kobayashi family also

up looking for Jiro Kobayashi, they began to enter the next stage, preparing

The Novel will be updated daily. Come back and continue reading tomorrow, everyone!

Comments ()

0/255